Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab and ATRA in Advanced Melanoma
NCT03200847Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Oct 2017
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin in melanoma, sponsored by University of Colorado Denver. Started Oct 2017; status: completed.
02
Drugs
tretinoin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT03200847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03200847.